ClinicalTrials.gg
RecruitingNCT07083700Updated Apr 15, 2026

Frame Support Study

An interventional study of Frame Access in Fertility Issues and Emotional Stress, sponsored by Inception Fertility Research Institute, LLC. Recruiting at 1 site in United States. Open to female participants aged 22 Years to 44 Years. Per ClinicalTrials.gov, last updated 2026-04-15.

Sponsored by Inception Fertility Research Institute, LLC · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
22 Years to 44 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-15

Among 10 studies in Infertility by Inception Fertility Research Institute, LLC — 5 open to participants now, 5 under way, none of them phase 3. Infertility · Inception Fertility Research Institute, LLC.

Started
2025
with 1 other
No phase
2 of 10
2 open now
Registered
6th of 10
by date

Among the 10 studies in Infertility by Inception Fertility Research Institute, LLC, this one is one of 2 that started in 2025, is one of 2 with no phase, and was the 6th registered.

Infertility

2,088 studies on the registry are indexed under Infertility; 356 are open to participants now.

Browse Infertility studies →

Open to participants now

5 of the 10 studies in Infertility by Inception Fertility Research Institute, LLC are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 234 Infertility studies recruiting now, 43 (18%) set no upper age limit and 185 (79%) stop at 75 or younger; 27 take children under 18; 76 take healthy volunteers.

This study: 22 Years to 44 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Infertility by Inception Fertility Research Institute, LLC, or all of them as a file.
02

Study summary

This is a randomized, controlled pilot study evaluating an intervention of non-significant risk. Potential subjects will be women who have completed an initial new patient consultation at one of the participating fertility clinics. Approximately 400 subjects will be enrolled from multiple fertility clinics.

Read the detailed description

All participants will complete a psychological questionnaire at enrollment. The questionnaire will include the Perceived Stress Scale (PSS), the Personal Health Questionnaire Depression Scale (PHQ-8), and the Copenhagen Multi-Centre Psychosocial Infertility- Fertility Problem Stress Scale (COMPI-FPSS). Participants will then be randomized 1:1 to the control group or intervention group. Participants in the control group will not be asked to take any additional action for six months. Participants in the intervention group will be given access to FRAME which will provide them with resources and an external care team to utilize during their fertility care. The intervention group is encouraged to use FRAME and its resources for six months. After six months, participants in both groups will complete a post-study psychological questionnaire. Data will be collected from medical records of all participants for up to nine months after enrollment.

03

Conditions studied

  • Fertility Issues
  • Emotional Stress
04

Who can participate

Ages eligible
22 Years to 44 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants have completed a new patient consult at one of the participating fertility clinics
  • Participants must be able to read, write and speak English
  • Participants must have access to a smart phone and internet connection

Exclusion criteria

Exclusion Criteria:

  • Patients who are currently using a fertility coach (in-person, remote, or online)
  • Patients planning egg freezing only
  • Patients who have received treatment at another fertility center
  • Patients planning egg donation
  • Patients currently participating in another clinical trial or study involving an intervention.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
400 participants (estimated)

Study arms

  • No intervention
    Control Group
  • Experimental
    Frame Access

    Behavioral: Frame Access

Interventions

  • BehavioralFrame Access

    FRAME™ provides a collaborative care platform that connects patients with evidence-based resources, education and support from a dedicated care team throughout their reproductive health care journey. More specifically, for patients exploring fertility treatment. Frame supplements the patient experience by providing patients with direct contact to board-certified fertility coaches and resources that can be accessed between appointments in a web-based application. Regular use of Frame's platform may help patients make lifestyle changes that can improve their fertility outcomes as well as boost their emotional health throughout the treatment process and reduce feelings of overwhelm and loneliness which can lead to patients dropping out of care.

06

What researchers measure

Primary outcomes

  1. Fertility treatment initiation

    To observe whether the patient started fertility treatment.

    Time frame: This will be evaluated at the end of patient's study participation, approximately 6 months post enrollment.

Secondary outcomes

  1. Time to fertility treatment initiation

    To observe the interval between study enrollment and start fertility treatment, if any.

    Time frame: This will be evaluated at the end of patient's study participation, approximately 6 months post enrollment.

Other outcomes

  1. Patient Health Questionnaire (PHQ-8)

    Patients will complete the Patient Health Questionnaire (PHQ-8) for depression screening at baseline and end of study. Scores of 10 and above suggest the presence of Major Depressive Disorder with higher scores being more severe.

    Time frame: From enrollment to six months after enrollment

  2. Copenhagen Multi-Centre Psychosocial Infertility- Fertility Problem Stress Scale (COMPI-FPSS)

    Patients will complete the Copenhagen Multi-Centre Psychosocial Infertility- Fertility Problem Stress Scale (COMPI-FPSS) at baseline and end of study. Lower scores indicate lower stress.

    Time frame: From enrollment to 6 months after enrollment.

  3. Perceived Stress Scale (PSS-10)

    Patients will complete the Perceived Stress Scale (PSS-10) at baseline and end of study. Scores will be interpreted as 0-13: Low stress; 14-26: Moderate stress; 27-40: High perceived stress.

    Time frame: From enrollment to 6 months after enrollment.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for Dec 2026, 18 months after the start.

Of 31 industry-sponsored interventional studies with no phase under Infertility, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 34. This study's planned 18 months is below that.

Counting every sponsor, half of 417 studies reached it within 24 months; a quarter within 10 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 24, 2025
First posted
Jul 24, 2025
StartActual
Jun 23, 2025
Primary completionEst.
Dec 2026
CompletionEst.
Jun 2027
Last update
Apr 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07083700
Collaborators
Reframe Health, Inc.
Responsible party
Sponsor
First posted
Jul 24, 2025
Start date
Jun 23, 2025
Primary completion
Dec 2026 (estimated)
Completion
Jun 2027 (estimated)
Last update
Apr 15, 2026

Study contacts

Amber Mendoza
Contact
amendoza@inceptionllc.com
346-393-2265

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Track this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to track

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion